EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ophthalmic screening in phakomatoses

Bijal Kikani, Sarah Stanley, Aparna Ramasubramanian

Frontiers in Cell and Developmental Biology · 03.07.2026 · 14

DOI: 10.3389/fcell.2026.1785180 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 03.07.2026. Verfasst von Bijal Kikani und 2 weiteren Autor:innen. Beteiligte Einrichtung: Medical College of Wisconsin, Milwaukee, WI, United States. Die Arbeit nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Phakomatoses are a heterogenous group of congenital neurocutaneous syndromes that are associated with a wide range of ocular and systemic presentations. The ocular conditions are important to consider as they may be asymptomatic early on, but progress to irreversible vision loss. Due to the variability of disease presentation, timely diagnosis is crucial to preserve visual outcomes. This article provides a comprehensive review of literature on nine major phakomatoses, including Neurofibromatosis type 1, Neurofibromatosis type 2, Tuberous Sclerosis complex, Sturge Weber syndrome, Von Hippel-Lindau, Ataxia Telangiectasia, Basal Cell Nevus Syndrome, Wyburn-Mason syndrome, and PHACE syndrome, which are commonly treated by ophthalmologists and other eye care professionals. Across these syndromes, some common vision threatening manifestation include glaucoma, optic pathway gliomas, and retinal hamartomas, with variability in the age of onset and disease progression. This article aims to provide syndrome specific screening guidelines to allow early detection of ocular pathology and promote multi-disciplinary care among ophthalmologists, pediatricians, and other providers to decrease visual morbidities and improve overall patient outcomes.

Schlagwörter

Stichwörter der Autor:innen

multi-disciplinary careneurocutaneous syndromesneurofibromatosisophthalmic screeningphakomatosesscreeningtuberous sclerosis

Autor:innen und Institutionen

  • Medical College of Wisconsin, Milwaukee, WI, United States.
  • SUNY Upstate Medical University, Norton College of Medicine, Syracuse, NY, United States.

Zitieren

APA

Kikani, B., Stanley, S., & Ramasubramanian, A. (2026). Ophthalmic screening in phakomatoses. Frontiers in Cell and Developmental Biology, 14. https://doi.org/10.3389/fcell.2026.1785180

Vancouver

Kikani B, Stanley S, Ramasubramanian A. Ophthalmic screening in phakomatoses. Frontiers in Cell and Developmental Biology. 2026;14. doi:10.3389/fcell.2026.1785180

BibTeX
@article{Kikani2026,
  author = {Kikani, Bijal and Stanley, Sarah and Ramasubramanian, Aparna},
  title = {Ophthalmic screening in phakomatoses},
  journal = {Frontiers in Cell and Developmental Biology},
  year = {2026},
  volume = {14},
  doi = {10.3389/fcell.2026.1785180}
}
Kostenlos starten →